Annexon, Inc.
corporate_fare Company Profile
Annexon, Inc. (NASDAQ:ANNX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for ANNX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Annexon Outlines Pivotal 2026 with Key Clinical & Regulatory Milestones for Lead Drug Candidates
- Annexon Files European MAA for GBS Therapy, Anticipates Pivotal Phase 3 Data for Dry AMD in H2 2026
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$206.69M
Diluted EPS
-$1.34
Op. Cash Flow
-$186.36M
Free Cash Flow
-$186.49M
Operating Income
-$216.41M
Cash & Equivalents
$162.05M
Debt / Equity
0.00×
Shares Outstanding
149.36M sh
Source: 10-K · filed 2026-03-30 · accession 0001193125-26-131782
show_chartPrice Chart
Loading chart...